Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥668,244 | CN¥539,524 | CN¥417,963 | CN¥293,879 |
| Short-Term Investments | CN¥0 | CN¥60,015 | CN¥0 | CN¥628 |
| Receivables | CN¥551,582 | CN¥390,323 | CN¥401,156 | CN¥193,969 |
| Inventory | CN¥902,354 | CN¥206,935 | CN¥181,036 | CN¥186,732 |
| Other Curr. Assets | CN¥36,936 | CN¥15,020 | CN¥274,878 | CN¥54,286 |
| Total Curr. Assets | CN¥2,513,034 | CN¥1,267,435 | CN¥1,050,477 | CN¥727,770 |
| Property Plant & Equip (Net) | CN¥696,430 | CN¥619,507 | CN¥630,405 | CN¥825,835 |
| Goodwill | CN¥230,532 | CN¥0 | CN¥0 | CN¥0 |
| Intangibles | CN¥137,206 | CN¥42,170 | CN¥43,183 | CN¥92,157 |
| Long-Term Investments | CN¥418 | -CN¥52,999 | CN¥14,474 | CN¥1,221 |
| Tax Assets | CN¥28,407 | CN¥60,015 | CN¥11,198 | CN¥17,817 |
| Other NC Assets | CN¥33,742 | CN¥65,591 | CN¥4,655 | CN¥5,923 |
| Total NC Assets | CN¥1,126,736 | CN¥674,269 | CN¥703,915 | CN¥942,952 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥3,639,770 | CN¥1,941,704 | CN¥1,754,392 | CN¥1,670,722 |
| Liabilities | – | – | – | – |
| Payables | CN¥117,719 | CN¥62,640 | CN¥66,775 | CN¥142,021 |
| Short-Term Debt | CN¥423,938 | CN¥150,012 | CN¥129,113 | CN¥338,505 |
| Tax Payable | CN¥49,783 | CN¥18,148 | CN¥3,334 | CN¥2,053 |
| Deferred Revenue | CN¥0 | CN¥2,350 | CN¥2,152 | CN¥56,102 |
| Other Curr. Liab. | CN¥446,227 | CN¥13,856 | CN¥112 | CN¥261 |
| Total Curr. Liab. | CN¥1,112,527 | CN¥269,804 | CN¥240,861 | CN¥536,888 |
| LT Debt | CN¥86,000 | CN¥0 | CN¥0 | CN¥0 |
| Deferred Rev, NC | CN¥8,055 | CN¥9,342 | CN¥10,628 | CN¥37,325 |
| Deferred Tax Liab, NC | CN¥52,896 | CN¥25,457 | CN¥41,631 | CN¥36,854 |
| Other NC Liab. | CN¥6,489 | CN¥0 | CN¥0 | CN¥10,000 |
| Total NC Liab. | CN¥176,046 | CN¥35,181 | CN¥52,260 | CN¥84,179 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥22,605 | CN¥382 | CN¥0 | CN¥0 |
| Total Liabilities | CN¥1,288,573 | CN¥304,985 | CN¥293,121 | CN¥621,067 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥504,445 | CN¥360,318 | CN¥258,952 | CN¥261,346 |
| Retained Earnings | CN¥1,001,529 | CN¥1,050,118 | CN¥1,058,995 | CN¥656,429 |
| AOCI | CN¥0 | CN¥0 | CN¥148,753 | CN¥139,702 |
| Other Equity | CN¥197,624 | CN¥178,233 | CN¥0 | CN¥0 |
| Total Equity | CN¥1,788,474 | CN¥1,636,719 | CN¥1,461,271 | CN¥1,049,655 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥562,723 | CN¥0 | CN¥0 | CN¥0 |
| Total Liab. & Tot. Equity | CN¥3,639,770 | CN¥1,941,704 | CN¥1,754,392 | CN¥1,670,722 |
| Net Debt | -CN¥158,306 | -CN¥389,512 | -CN¥288,850 | CN¥44,626 |